TSX:PLC - Post Discussion
Post by
retiredcf on Nov 13, 2020 8:19am
TD
Have PLC rated as a Buy with a $33.00 target. GLTA
Park Lawn Corp.
(PLC-T) C$29.25
Q3/20 First Look Event
Park Lawn reported Q3/20 results that were broadly in line with Street expectations. Revenue was $83.8mm (up 26% y/y), versus our estimate/consensus of $83.7mm/ $83.3mm. Adjusted EBITDA (net of NCI) was $19.1mm (up 26% y/y), versus our estimate/consensus of $20.0mm/$19.4mm.
9:30 a.m. ET conference call (647-427-7450 or 888-231-8191; code: 7388398).
Impact: NEUTRAL
-
Our overall view on Park Lawn remains unchanged following the Q3/20 results. Revenue was in line with our forecast and we believe the overall revenue outlook remains highly favorable near-term, particularly against the backdrop of rising COVID-19 case counts. While EBITDA came in ~5% below our forecast, this was largely owing to increased sales commissions due to strength in cemetery sales and we would note that EBITDA margins were relatively consistent y/y and q/q. We believe Park Lawn remains on track for ~26% EBITDA margins exiting F2022.
-
Overall organic growth in Q3/20 was 11%, modestly above our forecast of ~9%. Organic growth was seen in both the cemetery and funeral businesses. At- need sales were higher y/y, which we believe is largely due to the direct and in- direct impacts of COVID-19. Pre-need cemetery sales increased in Q3/20 as stay- at-home-orders were relaxed in many regions and with COVID-19 serving as a triggering event for clients. We believe lower average revenue per call was likely a marginal offset.
-
Park Lawn remains engaged on M&A and continues to move forward on its capex investments. We believe M&A will continue to be the most significant growth driver for Park Lawn moving forward and expect that it will remain active on M&A near-term. We estimate pro-forma available liquidity for Park Lawn (following its two recently announced acquisitions) is ~$136mm and pro-forma leverage (incl. convertible debentures and leases) is ~2.7x. Leverage for compliance purposes at the end of Q3/20 was only ~1.5x, well below covenants.
-
We believe organic growth could remain strong into H1/21. We anticipate that strength in at-need volumes should continue in the coming months, driven by continued death rates above normal levels, which we believe is also supportive of pre-need cemetery sales.
Be the first to comment on this post